Almirall J, Montoliu J, Torras A, Revert L
Nephrology Service, Hospital Clinic, University of Barcelona, Spain.
Nephron. 1989;53(3):273-5. doi: 10.1159/000185757.
A 36-year-old man with ankylosing spondylitis, amyloidosis and chronic renal failure on maintenance hemodialysis developed severe hypoglycemia while being treated with propoxyphene. Upon discontinuation of the drug blood glucose levels returned to normal and hypoglycemia did not recur. Simultaneously with hypoglycemia, plasma glucagon and growth hormone levels were appropriately raised and serum insulin levels were adequately suppressed, thus ruling out hyperinsulinemia as the cause of hypoglycemia. A review of the literature disclosed four similar cases of propoxyphene-induced hypoglycemia, two of them with renal dysfunction. Propoxyphene should be remembered as a potential cause of hypoglycemia, particularly in patients with renal failure.
一名36岁患有强直性脊柱炎、淀粉样变性病且因慢性肾衰竭接受维持性血液透析的男子,在接受丙氧芬治疗时发生了严重低血糖。停用该药物后血糖水平恢复正常,且低血糖未再次出现。在发生低血糖的同时,血浆胰高血糖素和生长激素水平适当升高,血清胰岛素水平得到充分抑制,从而排除了高胰岛素血症作为低血糖病因的可能性。文献回顾发现了4例丙氧芬诱发低血糖的类似病例,其中2例伴有肾功能不全。应记住丙氧芬是低血糖的一个潜在病因,尤其是在肾衰竭患者中。